Journal of Clinical Oncology (JCO) Podcast Podcast Episodes Online

Loading podcasts

Fetching podcast shows and categories...

Loading page

Opening Radio and Podcast...

Ready2SERAustralia · College Radio, World Music

Live--:--

Journal of Clinical Oncology (JCO) Podcast Podcast Episodes Online | Radio and Podcast

Episodes

50 of 455 episodes

JCO Article Insights: LEAP-010 Study in Recurrent/Metastatic Head and Neck Cancer

Host Jake New summarizes and offers insights into the JCO article by Licitra et al., "Pembrolizumab With or Without Lenvatinib as First-Line...

10:41Apr 27, 2026

Infections in Two Diet Strategies in HSCT and Leukemia Patients

Guest Dr. John Wingard and host Dr. Davide Soldato discuss JCO article, " Randomized Non-inferiority Trial of a Liberalized Diet Versus the...

20:40Apr 9, 2026

JCO Article Insights: ctDNA in DLBCL - Ready for Prime Time?

In this episode of JCO Article Insights, host Dr. Ash Gurumurthi summarizes JCO articles, " Phased Variant–Supported Circulating Tumor DNA a...

13:53Mar 30, 2026

The CISTO Study: Radical Cystectomy or Bladder-Sparing Therapy for Recurrent NMIBC

Guest Dr. John Gore and host Dr. Davide Soldato discuss JCO article, " 12-Month Results from the CISTO Study Comparing Radical Cystectomy Ve...

19:20Mar 12, 2026

JCO Article Insights: Atezolizumab, Bevacizumab, and Non-Platinum Chemotherapy for PROC

In this episode of JCO Article Insights, host Dr. Melis Canturk summarizes the article, " Atezolizumab With Bevacizumab and Nonplatinum Chem...

06:21Feb 23, 2026

JCO Article Insights: Ribociclib Plus Letrozole in Recurrent LGSOC: GOG 3026

In this episode of JCO Article Insights, host Dr. Melis Canturk summarizes the article, " Phase 2 Trial of Ribociclib plus Letrozole in Wome...

06:41Feb 23, 2026

NCI Working Group on Biochemically Recurrent Prostate Cancer

Host Dr. Davide Soldato and guests Dr. David Einstein and Dr. Ravi Madan discuss JCO article, " National Cancer Institute's Working Group on...

28:15Feb 12, 2026

Association Between EOL SACT and Healthcare Utilization

Host Dr. Davide Soldato and guests Dr. Kerin Adelson and Dr. Maureen Canavan discuss JCO article " Association Between Systemic Anticancer T...

23:00Jan 8, 2026

Milan Consensus Endpoints for Bladder Preservation in MIBC

Guests Dr. Andrea Necchi, Dr. Ashish Kamat and host Dr. Davide Soldato discuss JCO article " End Points for the Next-Generation Bladder-Spar...

27:18Dec 11, 2025

JCO at 2025 ASH: Pirtobrutinib in Untreated CLL

JCO Editor-in-Chief Dr. Jonathan Friedberg is joined by colleagues Dr. Jennifer Woyach, Dr. Wojciech Jurczak, and Dr. Matthew Davids to disc...

20:17Dec 9, 2025

JCO at ASH 2025: A New Validated Staging System for AL Amyloidosis: AL-ISS

JCO Editorial Fellow Peter Li and author Dr. Jahanzaib Khwaja discuss the ASH 2025 Simultaneous Publication article, " A New Validated Stagi...

15:02Dec 7, 2025

JCO Article Insights: Simultaneous Durvalumab and CRT in Unresectable Stage III NSCLC

In this episode of JCO Article Insights, host Dr. Ece Cali Daylan interviews author Dr. Jeffrey Bradley about the article, " Simultaneous Du...

10:31Nov 24, 2025

Health Outcomes in Older Childhood Cancer Survivors

Guest Dr. Rusha Bhandari and host Dr. Davide Soldato discuss JCO article "Health Outcomes Beyond Age 50 Years in Survivors of Childhood Canc...

21:22Nov 20, 2025

Long-Term Remission After Cilta-cel in Patients With RRMM

Guest Dr. Sundar Jagannath and host Dr. Davide Soldato discuss JCO article " Long-Term (≥5-Year) Remission and Survival After Treatment With...

27:31Nov 13, 2025

JCO Article Insights: Xevinapant Plus Chemoradiotherapy in Unresected LA SCCHN

In this episode of JCO Article Insights, host Dr. Lauren Shih summarizes the article, " Xevinapant or Placebo Plus Platinum-Based Chemoradio...

08:25Oct 27, 2025

Income Among Adolescents and Young Adults Surviving Cancer

Host Dr. Shannon Westin and guest Dr. Giancarlo Di Guiseppe discuss the JCO article " Long-Term Dynamic Financial Impacts Among Adolescents...

16:16Oct 9, 2025

JCO Article Insights: Phase I DLL3/CD3 T-Cell Engager in DLL3-Positive SCLC or NECs

In this JCO Article Insights episode, Dr. Ece Cal interviews Dr. Martin Wermke, author of the JCO article, " Phase I Dose-Escalation Results...

12:51Sep 29, 2025

TTFields in Locally Advanced Pancreatic Adenocarcinoma

Host Dr. Shannon Westin and guest Dr. Hani Babiker discuss the JCO article " Tumor Treating Fields With Gemcitabine and Nab-Paclitaxel for L...

18:42Sep 11, 2025

JCO at WCLC: Multinational Pivotal Study of Sunvozertinib in Exon20ins NSCLC

JCO fellow Dr. Ece Cali speaks with JCO Associate Editor Dr. Thomas E. Stinchcombe to discuss the JCO article "Phase 2 Dose-Randomized Study...

07:45Sep 9, 2025

Racial and Ethnic Disparities Among Medicare Beneficiaries

Host Davide Soldato and guest Dr. John K. Lin discuss the JCO article " Racial and Ethnic Disparities Along the Treatment Cascade Among Medi...

28:43Aug 28, 2025

JCO Article Insights: Lymph Node Dissection for Lung Cancer

In this JCO Article Insights episode, Dr. Joseph Matthew interviews authors Dr. Yang Zhang and Dr. Haiquan Chen about their recently publish...

21:49Aug 25, 2025

JCO Article Insights: IMS-IMWG Consensus on High-Risk Multiple Myeloma

In this JCO Article Insights episode, Michael Hughes summarizes "International Myeloma Society and International Myeloma Working Group Conse...

24:50Jul 28, 2025

JCO Article Insights: Pooled Taletrectinib Efficacy and Safety

In this JCO Article Insights episode, host Peter Li summarizes " Taletrectinib in ROS1-Mutated Non–Small Cell Lung Cancer: TRUST " by Pérol...

15:02Jun 30, 2025

JCO at ASCO Annual Meeting: Neoadjuvant Osimertinib for Resectable EGFR-Mutated NSCLC

JCO Editorial Fellow Dr. Ece Cali Daylan and JCO Associate Editor Dr. Thomas Stinchcombe discuss the ASCO 2025 Simultaneous Publication pape...

06:54Jun 2, 2025

JCO at ASCO Annual Meeting: Lenvatinib Plus Pembrolizumab and Chemotherapy in Gastric Cancer

JCO Editorial Fellow Dr. Peter Li and JCO Associate Editor Dr. Andrew Ko discuss the ASCO 25 Simultaneous Publication paper " Lenvatinib Plu...

06:52May 31, 2025

JCO at ASCO Annual Meeting: TTFields in Locally Advanced Pancreatic Adenocarcinoma

JCO Editorial Fellow Peter Li and JCO Associate Editor Eileen O'Reilly discuss the ASCO 25 Simultaneous Publication paper " Tumor-Treating F...

06:24May 31, 2025

JCO at ASCO Annual Meeting: Avelumab Plus Cetuximab vs. Avelumab in Advanced cSCC

JCO Editorial Fellow Dr. Ece Cali Daylan and JCO Associate Editor Dr. Grant McArthur discuss the ASCO 2025 Simultaneous Publication paper "...

08:42May 31, 2025

JCO at ASCO Annual Meeting: Use of Low-Value Cancer Treatments in Medicare

JCO Editorial Fellow Dr. Lauren Shih and JCO Associate Editor Dr. Stephanie Wheeler discuss the ASCO 25 Simultaneous Publication paper "Use...

08:17May 31, 2025

JCO Article Insights: Double Hit Myeloma Correlates With Adverse Patient Outcome

In this JCO Article Insights episode, host Michael Hughes summarizes "Co-Occurrence of Cytogenetic Abnormalities and High-Risk Disease in Ne...

15:50May 29, 2025

Pembrolizumab and Bevacizumab for Melanoma Brain Metastases

Host Dr. Davide Soldato and guest Dr. Harriet Kluger discuss the JCO article "Phase II Trial of Pembrolizumab in Combination With Bevacizuma...

23:59May 8, 2025

JCO Article Insights: ESPAC4 Long-Term Follow-Up in Pancreatic Cancer

In this JCO Article Insights episode, host Joseph Mathew summaries Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the...

06:47Apr 28, 2025

Longitudinal Results from the Nationwide Just ASK Initiative to Promote Routine Smoking Assessment

Host Dr. Davide Soldato and guests Dr. Jessica Burris discuss the article " Longitudinal Results from the Nationwide Just ASK Initiative to...

26:50Apr 10, 2025

JCO Article Insights: Smoking Assessment

In this JCO Article Insights episode, Lauren Shih summaries " Longitudinal Results From the Nationwide Just ASK Initiative to Promote Routin...

08:35Mar 31, 2025

Botensilimab Plus Balstilimab in Advanced Sarcomas

Dr. Shannon Westin and her guest, Dr. Breelyn Wilky, discuss the JCO article, ""Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-associat...

21:00Mar 13, 2025

JCO Article Insights: Long-Term Outcome of Neoadjuvant Chemotherapy for Rectal Cancer

In this JCO Article Insights episode, Peter Li summarizes " Neoadjuvant Modified Infusional Fluorouracil, Leucovorin, and Oxaliplatin With o...

08:47Feb 24, 2025

High Omega-3, Low Omega-6 Diet with Fish Oil and Prostate Cancer

Host Dr. Shannon Westin and guests Dr. Bill Aronson discuss the article "High Omega-3, Low Omega-6 Diet With Fish Oil for Men With Prostate...

12:12Feb 13, 2025

JCO Article Insights: TROPION-Lung01 Dato-DXd in NSCLC

In this JCO Article Insights episode, Ece Cali summarizes findings from the JCO article, " Datopotamab Deruxtecan Versus Docetaxel for Previ...

10:21Jan 27, 2025

Air Pollution and Breast Cancer Incidence

Host Dr. Davide Soldato and his guests Dr. Ann Wu and Dr. Alexa White discuss the article " Air Pollution and Breast Cancer Incidence in the...

25:43Jan 9, 2025

JCO Article Insights: Adoption of Capivasertib in Metastatic Hormone Receptor–Positive, HER2-Negative Breast Cancer – Efficacy, Toxicity and Treatment Sequencing

In this JCO Article Insights episode, Giselle de Souza Carvalho provides a summary on " Navigating Treatment Pathways in Metastatic Hormone...

09:01Dec 30, 2024

Overcoming Barriers to Make Patient-Partnered Research a Reality

Host Dr. Davide Soldato and guests Dr. Suzanne George and Liz Salmi discuss their JCO article "Overcoming Systemic Barriers to Make Patient-...

34:38Dec 12, 2024

JCO Article Insights: Nivolumab + Relatlimab v Nivolumab + Ipilimumab in Melanoma

In this JCO Article Insights episode, Rohit Singh provides a summary on " First-Line Nivolumab Plus Relatlimab Versus Nivolumab Plus Ipilimu...

09:42Nov 25, 2024

Quality of Treatment Selection

Host Dr. Davide Soldato and Dr. Aaron Mitchell discuss the JCO article " Quality of Treatment Selection for Medicare Beneficiaries With Canc...

25:05Nov 14, 2024

JCO Article Insights: HLA-Mismatched Unrelated Donor HCT With PTCy

In this JCO Article Insights episode, Alexandra Rojek provides a summary on "Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Diseas...

09:52Oct 28, 2024

Adjuvant Pembrolizumab for High-Risk, dMMR Endometrial Cancer

Dr. Shannon Westin and her guest, Dr. Brian Slomovitz discuss the article "Pembrolizumab or Placebo Plus Adjuvant Chemotherapy With or Witho...

16:40Oct 16, 2024

Combining Response and Toxicity Data to Implement Project Optimus

In this JCO Article Insights episode, Subodh Selukar interviews author Dr. Robert Maki on " Combining Response and Toxicity Data to Implemen...

23:55Sep 30, 2024

CBT-I for Cancer-Related Cognitive Impairment

Host Dr. Davide Soldato and Dr. Shelia Garland discuss the JCO article " Randomized Controlled Trial of Virtually Delivered Cognitive Behavi...

31:21Sep 12, 2024

JCO Article Insights: Assisted Reproduction in Breast Cancer Patients

In this episode of JCO Article Insights, Dr. Giselle de Souza Carvalho interviews Dr. Hatem Azim and Dr. Ann partridge on their JCO article...

22:48Aug 26, 2024

Multi-Cancer Early Detection Testing for High-Risk Patients

Host Dr. Davide Soldato interviews Dr. Sana Raoof to discuss the JCO article Turning the Knobs on Screening Liquid Biopsies for High-Risk Po...

30:29Aug 8, 2024

JCO Article Insights: Back to the Drawing Board: Overcoming Resistance to PD-1 Blockade

In this episode of JCO Article Insights, Rohit Singh interviews Dr. Ticiana Leal on the editorial, " Back to the Drawing Board: Overcoming R...

17:27Jul 29, 2024

Functional Disability Among US Cancer Survivors

Dr. Shannon Westin and her guest, Dr. Chao Cao, discuss the paper " Prevalence and Cancer-Specific Patterns of Functional Disability Among U...

16:12Jul 11, 2024